1,782 followers
3,021 followers
SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion. #COVID19 #clinicaltrials #comostat #IDtwitter htt
1,782 followers
312 followers
New article: SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion https://t.co/WQPSIBm5fJ #coronavirus #CO